0
2
interesting
-
2
8/10/22 at 10:24pm
Organization
Medical News Today
Author
Corrie Pelc
32 words
0
Comments
Biotechnology company Verve Therapeutics launched the first human clinical trial for a gene-editing medication aimed at lowering cholesterol.
You are the first to view
https://www.medicalnewstoday.com/articles/high-cholesterol-new-crispr-treatment-trial-could-offer-permanent-cure
Create an account
or login to join the discussion